Vivos Therapeutics, Inc. (VVOS) Return on equity 2020–2024
Vivos Therapeutics, Inc. (VVOS) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-140.0%FY2024 · since FY2020: -71.3% → -140.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -140.0% | +3164.9 pp |
| FY2023 | -3304.9% | -2808.2 pp |
| FY2022 | -496.7% | -417.2 pp |
| FY2021 | -79.4% | -8.2 pp |
| FY2020 | -71.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice